2020
DOI: 10.1007/s00210-020-01826-0
|View full text |Cite
|
Sign up to set email alerts
|

Serotonin 5HT2A receptor antagonism mediated anti-inflammatory and anti-fibrotic effect in adriamycin-induced CKD in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(5 citation statements)
references
References 44 publications
0
5
0
Order By: Relevance
“…It is important to note that, unlike psilocybin and 4-AcO-DMT, ketanserin is a 5-HT2A antagonist. While ketanserin has been shown to inhibit inflammation by reducing IL-6 and ameliorate kidney fibrosis by decreasing TGF-beta and collagen production [ 5 , 35 ], ketanserin demonstrated a moderate ability to reduce COX-2 levels (−1.7×). Our data suggest that selective 5-HT2A agonists (psilocybin) are stronger anti-inflammatory agents than antagonists, specifically ketanserin ( Table 1 ).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It is important to note that, unlike psilocybin and 4-AcO-DMT, ketanserin is a 5-HT2A antagonist. While ketanserin has been shown to inhibit inflammation by reducing IL-6 and ameliorate kidney fibrosis by decreasing TGF-beta and collagen production [ 5 , 35 ], ketanserin demonstrated a moderate ability to reduce COX-2 levels (−1.7×). Our data suggest that selective 5-HT2A agonists (psilocybin) are stronger anti-inflammatory agents than antagonists, specifically ketanserin ( Table 1 ).…”
Section: Discussionmentioning
confidence: 99%
“…While synergy between ketanserin and eugenol or capsaicin is intriguing, their clinical use is contraindicated due to the known adverse effects of ketanserin. Nevertheless, the anti-inflammatory effects seen through 5-HT2A receptor antagonism are known to be mediated through both MEK/ERK to reduce nitrosative stress [ 54 ] and have been shown to inhibit IL-6 production as well [ 35 , 54 , 55 ]. As MEK/ERK both regulate IL-6 production through Stat3 signaling [ 56 ], this is likely how ketanserin can further reduce IL-6 expression when ketanserin is combined with TRP ligands that are not known to interact with the MEK/ERK/STAT3/IL-6 pathway.…”
Section: Discussionmentioning
confidence: 99%
“…PAI-1, which promotes fibrosis through inhibition of MMP activation, is also a factor that promotes TGF-β1 synthesis, while its expression is enhanced by TGF-β1 [ 104 ]. Enhanced serotonin signaling mediated by 5-hydroxytryptamine receptors resulting in increased transcription of TGF-β1 has been identified in some fibrotic diseases [ 105 , 106 ]. TGF-β1 is synthesized in a linked state with latency-associated polypeptide (LAP), then forms a complex with latent TGF-β-binding protein (LTBP) or a leucine-rich repeat containing (LRRC) protein, and is subsequently released outside the cell [ 107 ].…”
Section: Core Signaling Pathways and Their Crosstalk Involved In Deve...mentioning
confidence: 99%
“…Real-time polymerase chain reaction was performed on Roche Light Cycler 480II for relative quantification of PDE-4A, B, D isoforms expression. Relative gene expression was calculated by double delta Ct (2-ΔΔct) method and was normalized to GAPDH as standard gene [29].…”
Section: Quantitative Gene Expression Analysis Of Different Pde-4 Iso...mentioning
confidence: 99%